P/E Ratio: Price to Earnings - Most used valuation metric
Analyzing Investment Quality
Processing 9 key metrics...
Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format
Standalone annual data is not available for this symbol.
Try switching to Consolidated view.
Loading shareholding data...
No insider trading data available
Standard pivot points - most widely used
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹1244.90 | +₹107.30 | +9.43% |
| R3 | ₹1200.60 | +₹63.00 | +5.54% |
| R2 | ₹1175.00 | +₹37.40 | +3.29% |
| R1 | ₹1156.30 | +₹18.70 | +1.64% |
| PIVOT | ₹1130.70 | -6.90 | -0.61% |
| CURRENT | ₹1137.60 | - | - |
| S1 | ₹1023.40 | -₹114.20 | -10.04% |
| S2 | ₹1067.70 | -₹69.90 | -6.14% |
| S3 | ₹1086.40 | -₹51.20 | -4.50% |
| S4 | ₹1112.00 | -₹25.60 | -2.25% |
is trading CPR, indicating
CPR is
Day's range: ~
Trading Inside opening range
| Company Name |
|---|
Advanced Enzyme Technologies Ltd |
Asian Paints Ltd |
Camlin Fine Sciences Ltd |
Fineotex Chemical Ltd |
Foseco India Ltd |
Jubilant Agri & Consumer Products Ltd |
Kiri Industries Ltd |
Platinum Industries Ltd |
Rossari Biotech Ltd |
Raghav Productivity Enhancers Ltd |
S H Kelkar & Company Ltd |
Vidhi Specialty Food Ingredients Ltd |
XPRO India Ltd |
Yasho Industries Ltd |

Tatva Chintan Pharma Chem Limited (TCPL) is a prominent Indian manufacturer and supplier of specialty chemicals, catering to both domestic and international markets. Their business model centers on providing high-quality, specialized chemical compounds for a diverse range of industrial applications. This specialization distinguishes them within the broader chemical industry, allowing them to focus on niche markets and develop strong expertise in their chosen areas.
A core component of TCPL's product portfolio lies in structure-directing agents (SDAs) used in the synthesis of zeolites. Zeolites are crystalline aluminosilicate minerals with various industrial applications, and TCPL's SDAs play a crucial role in controlling the structure and properties of these materials. This demonstrates their involvement in a technologically advanced segment of the chemical industry requiring sophisticated chemical engineering and synthesis expertise.
Beyond zeolite synthesis, TCPL produces and distributes a wide array of other specialty chemicals. This includes phase-transfer catalysts, which accelerate chemical reactions; electrolyte salts for cutting-edge energy storage technologies like supercapacitors and zinc-ion batteries; and various pharmaceutical and agrochemical products. This broad product range underscores their ability to adapt to evolving market demands and serve multiple sectors.
The company's customer base spans a multitude of industries, highlighting the versatility of their chemical offerings. These include the automotive sector, refineries, pharmaceutical manufacturers, agrochemical producers, manufacturers of paints and coatings, dyes and pigments, personal care products, and companies in the flavor and fragrance industries. This widespread reach indicates the diverse applications of their specialized chemicals and their success in penetrating significant market segments.
In summary, Tatva Chintan Pharma Chem Limited operates a successful business focused on the manufacturing and sale of high-value specialty chemicals. Their expertise in specific areas, coupled with a diversified customer base and a broad product portfolio, positions them as a significant player within the global chemical industry. The company's continued focus on innovation and adaptation to emerging technological needs ensures their continued relevance and growth prospects within the market.
Plot No. 353 G.I.D.C, Makarpura
Vadodara
GUJARAT
IN
Tel: 917574848533
Website:https://www.tatvachintan.com/
Group: Materials
Sector: Materials
Industry: Chemicals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 689
IPO Date: 29/07/2021
Mr. Chintan Shah
Executive Chairman of the Board, Managing Director
Mr. Ashok Bothra
Chief Financial Officer
Mr. Ishwar Nayi
Compliance Officer, Company Secretary
Mr. Ajaykumar Patel
Whole Time Director
Mr. Shekhar Somani
Whole Time Director
Dr. Manher Desai
Non-Executive Independent Director
Mr. Subhash Patel
Non-Executive Independent Director
Dr. Avani Umatt
Non-Executive Independent Director
Get answers to the most common questions about Tatva Chintan Pharma Chem Ltd stock price, fundamentals, financial metrics, and investment analysis